To evaluate the prognostic value of baseline serum neurofilament light chain (sNfL) for future MRI disease activity in diverse racial/ethnic subpopulations (Asian, Black, and Other) of people with relapsing multiple sclerosis (pwRMS) in the Phase 3 ASCLEPIOS I/II trials.
No takes yet. Share an insight, caveat, or question.
Freeman et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: